...
【24h】

Lack of Efficacy of Topical Furfuryl Palmitate in Pediatric Atopic Dermatitis: A Randomized Double-Blind Study

机译:小儿特应性皮炎外用糠酸糠酸棕榈酯的疗效缺乏:一项随机双盲研究

获取原文
           

摘要

Introduction: Atopic dermatitis is a common disease in children. It is usually treated with topical steroids and/or calcineurin inhibitors in association with emollients but topical antioxidants have been recently introduced as a therapeutic option for children. The aim of this study was to evaluate the efficacy and tolerability of furfuryl palmitate, a new antioxidant molecule, in a multicenter, randomized, doubleblind, vehicle-controlled study.Patients and Methods: Children with atopic dermatitis were randomized into 2 groups treated for 2 weeks. One group of children (n=60) was treated with a basic emollient cream and the other (n=57) was treated with the same cream enriched with furfuryl palmitate.Results: In both groups, there was a signifi cant reduction (P.001) in atopic dermatitis?measured using the SCORAD index?after 14 days. The reduction in the per-protocol analysis was higher for the basic cream. Treatment success was defined as a reduction of 20% or more in the SCORAD index from baseline to day 14. Patients who used treatment not permitted by the protocol were also considered treatment failures. The intention-to-treat analysis showed 70% positive results for the basic treatment and 29% for the treatment containing furfuryl palmitate (P.0001) with a number needed to treat of 2.4 (95% confidence interval, 1.6-4.6). The emollient cream without furfuryl palmitate was observed to be more efficacious by pediatricians and parents, and no differences were reported between the 2 products in terms of tolerability.Conclusions: Both products proved to be efficacious in treating atopic dermatitis in children, but the emollient cream not containing furfuryl palmitate showed better clinical efficacy.Key words: Atopic dermatitis. Children. Furfuryl palmitate. Topical administration.
机译:简介:特应性皮炎是儿童的常见病。通常使用局部类固醇和/或钙调神经磷酸酶抑制剂与润肤剂联合治疗,但是最近已引入局部抗氧化剂作为儿童的治疗选择。这项研究的目的是在多中心,随机,双盲,载体对照研究中评估一种新的抗氧化剂分子棕榈酸酯糠酸酯的疗效和耐受性。患者和方法:将特应性皮炎患儿随机分为两组,分别接受2组和2组治疗周。一组儿童(n = 60)接受碱性润肤乳霜治疗,另一组(n = 57)接受相同的富含糠酸棕榈酸酯的乳霜治疗。结果:两组儿童均明显减少(P < .001)在特应性皮炎中(14天后使用SCORAD指数测量)。对于基本乳膏,按方案分析的减少幅度更大。治疗成功的定义是,从基线到第14天,SCORAD指数降低20%或更多。使用该方案不允许的治疗的患者也被视为治疗失败。意向治疗分析显示,基本治疗的阳性结果为70%,棕榈酸糠基酯(P <.0001)的治疗为29%,治疗需要2.4(95%置信区间1.6-4.6)。儿科医生和父母观察到不含糠酸棕榈酸酯的润肤霜更有效,并且在耐受性方面,两种产品之间均未见任何差异。关键词:异位性皮炎。孩子们糠酸棕榈酸酯。局部管理。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号